Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
JHEP Reports : Innovation in Hepatology|March 13, 2023
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cellsAbhishek Aggarwal, Pamela M Odorizzi, Jens Brodbeck, et al.The Journal of Experimental Medicine|June 6, 2007
A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritisKenneth J Katschke, Karim Y Helmy, Micah Steffek, et al.The Journal of Experimental Medicine|January 13, 2016
IL-33 amplifies an innate immune response in the degenerating retinaHongkang Xi, Kenneth J Katschke, Yun Li, et al.Hepatology (Baltimore, Md.)|January 11, 2023
Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progressionAdrien Guillot, Marc Winkler, Milessa Silva Afonso, et al.Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.Journal of Crohn'S & Colitis|April 29, 2017
αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative ColitisChristopher A Lamb, John C Mansfield, Gaik W Tew, et al.JHEP Reports : Innovation in Hepatology|December 24, 2021
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infectionNicholas van Buuren, Ricardo Ramirez, Scott Turner, et al.Molecular Cancer|January 5, 2025
Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy responseBenjamin H Jenkins, Ian Tracy, Maria Fernanda S D Rodrigues, et al.The American Journal of Gastroenterology|October 16, 2013
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imagingWilliam A Faubion, Joel G Fletcher, Sharon O'Byrne, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapyQian Gong, Qinglin Ou, Shiming Ye, et al.Pageof 6